Reports

Ideas That Generate Results

Global Influenza Vaccine Market Analysis

Global Influenza Vaccine Market Analysis

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Oct, 2011| No. of Pages : 60

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1200.00
CD-ROM Mail Delivery
US$ 1400.00
Hard Copy Mail Delivery
US$ 1400.00
Electronic Access - Multi-User License
US$ 1800.00

List of Figures:

Figure 4-1: Global - Vaccine Market (Billion US$), 2010-2013
Figure 4-2: Global - Seasonal Influenza Vaccine Production (Million Doses), 2010-2013
Figure 4-3: Global - Seasonal Influenza Vaccine Market (Billion US$), 2010-2013
Figure 4-4: Global - Fluzone Sales (Million US$), 2010-2013
Figure 4-5: Global - Flumist Sales (Million US$), 2010-2013
Figure 4-6: Global - Fluarix and FluLaval Sales (Million GBP), 2010-2013
Figure 4-7: Global - Fluarix and FluLaval Sales by Region (%), 2010
Figure 4-8: Global- Optaflu Sales (Million US$), 2010-2013
Figure 5-1: US - Seasonal Influenza Vaccine Production (Million Doses), 2008-09 to 2011-12
Figure 5-2: US - Seasonal Influenza Vaccine Production by Manufacturer (%), 2010-11
Figure 5-3: US - Seasonal Influenza Vaccine Market (Billion US$), 2010-2013
Figure 5-4: US - Seasonal Flu Vaccine Sales by Providers (%), 2010-11
Figure 5-5: EU - Seasonal Influenza Vaccination Coverage (%), 2006-07 & 2007-08
Figure 5-6: UK - Seasonal Influenza Vaccination Coverage for Elderly and Clinical Risk Group (%), 2009-2011
Figure 5-7: UK - Seasonal Influenza Vaccine Market (Million US$), 2010-2013
Figure 5-8: Germany - Seasonal Influenza Vaccine Market (Million US$), 2010-2013
Figure 5-9: France - Seasonal Influenza Vaccine Market (Million US$), 2010-2013
Figure 5-10: Spain - Seasonal Influenza Vaccine Market (Million US$), 2010-2013
Figure 5-11: Italy - Seasonal Influenza Vaccine Market (Million US$), 2010-2013
Figure 5-12: Japan - Seasonal Influenza Vaccine Market (Million US$), 2010-2013

List of Tables:

Table 4-1: Global - Key Indicators of Influenza
Table 5-1: US - Seasonal Influenza Vaccination Coverage by Group (%), 2008-09 to 2010-11
Table 5-2: EU - Seasonal Influenza Vaccine Recommended for People with Underlying Conditions (2008-2009)
Table 5-3: UK - Seasonal Influenza Vaccines & Manufacturers (2011-12)
Table 5-4: UK - Seasonal Influenza Vaccine Procurement Cost (Million £)
Table 5-5: Germany - Seasonal influenza Vaccination Coverage in Adult Population by Age Group (%), 2007-08 & 2008-09
Table 5-6: France - Seasonal Influenza Vaccine Coverage by Age Group, Gender and At-risk Individual (%), 2008-09 & 2009-10
Table 5-7: Spain - Seasonal Influenza Vaccine Coverage by Gender and Risk Group (Doses), 2009-10 & 2010-11
Table 5-8: Italy - Seasonal Influenza Vaccine Coverage Rate among Various Groups (%)
Table 5-9: China - Key Seasonal Influenza Vaccine Market Statistics
Table 6-1: US - Seasonal Influenza Vaccine R&D Contracts Awarded to Manufacturers
Table 7-1: Novartis - Seasonal Influenza Vaccines by Phase
Table 7-2: GSK - Key Seasonal Influenza Vaccines, Patent Expiration Date, and Competitive Brands

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.